While it remains to be determined whether ITGAL/CD11a associates with immune evasion in NSCLC via LFA-1 or binding to CD18, ITGAL strongly correlates with TIGIT and CD96 at a Spearman rho ≥ 0.8 in both LUAD and LUSC (Figure 4A). The gene discussed is CD96; the disease is non-small cell lung carcinoma.